Microbial Sensitivity Tests
"Microbial Sensitivity Tests" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses).
| Descriptor ID |
D008826
|
| MeSH Number(s) |
E01.370.225.875.595 E05.200.875.595 E05.337.550.400
|
| Concept/Terms |
Microbial Sensitivity Tests- Microbial Sensitivity Tests
- Microbial Sensitivity Test
- Sensitivity Test, Microbial
- Sensitivity Tests, Microbial
- Test, Microbial Sensitivity
- Tests, Microbial Sensitivity
- Drug Sensitivity Assay, Microbial
Minimum Inhibitory Concentration- Minimum Inhibitory Concentration
- Concentration, Minimum Inhibitory
- Concentrations, Minimum Inhibitory
- Inhibitory Concentration, Minimum
- Inhibitory Concentrations, Minimum
- Minimum Inhibitory Concentrations
Bacterial Sensitivity Tests- Bacterial Sensitivity Tests
- Tests, Bacterial Sensitivity
- Sensitivity Tests, Bacterial
- Test, Bacterial Sensitivity
- Bacterial Sensitivity Test
- Sensitivity Test, Bacterial
|
Below are MeSH descriptors whose meaning is more general than "Microbial Sensitivity Tests".
Below are MeSH descriptors whose meaning is more specific than "Microbial Sensitivity Tests".
This graph shows the total number of publications written about "Microbial Sensitivity Tests" by people in this website by year, and whether "Microbial Sensitivity Tests" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 4 | 4 |
| 1998 | 0 | 2 | 2 |
| 1999 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2002 | 0 | 2 | 2 |
| 2003 | 0 | 1 | 1 |
| 2004 | 1 | 1 | 2 |
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 0 | 1 | 1 |
| 2010 | 0 | 4 | 4 |
| 2012 | 0 | 1 | 1 |
| 2013 | 0 | 1 | 1 |
| 2016 | 0 | 2 | 2 |
| 2017 | 0 | 2 | 2 |
| 2018 | 0 | 2 | 2 |
| 2019 | 0 | 2 | 2 |
| 2020 | 0 | 2 | 2 |
| 2021 | 0 | 2 | 2 |
| 2022 | 0 | 1 | 1 |
| 2023 | 0 | 4 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Microbial Sensitivity Tests" by people in Profiles.
-
Utilization of an immunochromatographic lateral flow assay for rapid detection of carbapenemase production in gram negative bacilli. Lab Med. 2023 Nov 02; 54(6):e204-e206.
-
The role of the plasmid-mediated fluoroquinolone resistance genes as resistance mechanisms in pediatric infections due to Enterobacterales. Front Cell Infect Microbiol. 2023; 13:1249505.
-
Distinct Origins and Transmission Pathways of blaKPCEnterobacterales across Three U.S. States. J Clin Microbiol. 2023 08 23; 61(8):e0025923.
-
Development of a Broth Microdilution Method To Characterize Chlorhexidine MICs among Bacteria Collected from 2005 to 2019 at Three U.S. Sites. Microbiol Spectr. 2023 06 15; 11(3):e0413422.
-
Computing antimicrobial use/antimicrobial resistance ratios: A novel way to assess inpatient antimicrobial utilization using current National Healthcare Safety Network metrics. Transpl Infect Dis. 2022 Oct; 24(5):e13924.
-
Regional Spread of blaNDM-1-Containing Klebsiella pneumoniae ST147 in Post-Acute Care Facilities. Clin Infect Dis. 2021 10 20; 73(8):1431-1439.
-
Genomic Update of Phenotypic Prediction Rule for Methicillin-Resistant Staphylococcus aureus (MRSA) USA300 Discloses Jail Transmission Networks with Increased Resistance. Microbiol Spectr. 2021 09 03; 9(1):e0037621.
-
Engineering Nanogels for Drug Delivery to Pathogenic Fungi Aspergillus fumigatus by Tuning Polymer Amphiphilicity. Biomacromolecules. 2020 08 10; 21(8):3112-3121.
-
A ?-Lactam Siderophore Antibiotic Effective against Multidrug-Resistant Gram-Negative Bacilli. J Med Chem. 2020 06 11; 63(11):5990-6002.
-
A Pilot Study of Chicago Waterways as Reservoirs of Multidrug-Resistant Enterobacteriaceae (MDR-Ent) in a High-Risk Region for Community-Acquired MDR-Ent Infection in Children. Antimicrob Agents Chemother. 2020 03 24; 64(4).